BIOFRONTERA ($BFRI) posted quarterly earnings results for Q2 2026 on Thursday, August 13th. The company reported earnings of -$0.05 per share, beating estimates of -$0.11 by $0.06. The company also reported revenue of $12,000,000, beating estimates of $10,710,000 by $1,290,000.
You can see Quiver Quantitative's $BFRI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOFRONTERA Hedge Fund Activity
We have seen 7 institutional investors add shares of BIOFRONTERA stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AIGH CAPITAL MANAGEMENT LLC removed 175,300 shares (-19.2%) from their portfolio in Q2 2026, for an estimated $165,746
- JANE STREET GROUP, LLC removed 32,820 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $26,551
- GEODE CAPITAL MANAGEMENT, LLC removed 32,611 shares (-29.8%) from their portfolio in Q2 2026, for an estimated $30,833
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 27,028 shares (+234.1%) to their portfolio in Q1 2026, for an estimated $21,865
- ROSALIND ADVISORS, INC. added 23,198 shares (+2.0%) to their portfolio in Q1 2026, for an estimated $18,767
- TWO SIGMA SECURITIES, LLC removed 13,476 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $10,902
- CITIGROUP INC removed 11,837 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $11,191
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
